Gartocharn cop with terminal brain tumour sketches NHS staff who have cared for him dailyrecord.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyrecord.co.uk Daily Mail and Mail on Sunday newspapers.
Patients diagnosed with a BRAF-mutated bowel cancer in Scotland will have a new treatment available to them if the disease is found to have spread PATIENTS in Scotland with a rare but particularly deadly form of colorectal cancer will have access to a new life-extending therapy on the NHS for the first time. The Scottish Medicines Consortium has given the go ahead for Braftovi to be used in combination with cetuximab in patients whose cancer has the BRAF V600 genetic mutation. This is present in around 15 per cent of patients with early-stage colorectal cancer and 6% of those whose disease has spread, with patients in this latter category typically surviving just four to six months from diagnosis.
Medicines for colorectal, skin and ovarian cancers are among four newly approved treatements for use in NHS Scotland.
The Scottish Medicines Consortium (SMC) announced it has accepted four new medicines for routine use from Monday including Encorafenib (Braftovi), hydrochloride (Ledaga), niraparib (Zejula) and Ravulizumab (Ultomiris).
Encorafenib (Braftovi) was accepted for use along with the medicine cetuximab for the treatment of colorectal cancer in patients with a gene mutation called “BRAF V600”.
It can be used when the cancer has spread elsewhere in the body after previously being treated with other medicines.
Great news for advanced #bowelcancer patients with a BRAF mutation living in Scotland. The Scottish Medicines Consortium has today approved BRAFTOVI® (encorafenib). This new drug offers hope to patients with very limited treatment options: https://t.co/LcCiOc6IQApic.twitter.com/BkSzRHAvaF
Nico Simeone to open charitable restaurant Beat 6 in Glasgow The team behind the Six by Nico group of restaurants is opening a new venue that will donate its profits to charity.
Called Beat 6, the restaurant, to be located on Whitehill Street in the Dennistoun are of Glasgow, will donate its profits towards the Beatson Cancer Charity, which supports the Beatson West of Scotland Cancer Centre
Restaurateur Nico Simeone and his wife Valentina have created the project to help the Beatson Cancer Charity help others in the same way it helped them. Valentina has benefitted from the treatment the Beatson provides having been diagnosed with Non-Hodgkin’s Lymphoma in May of 2015, at the age of 25.
The Simeone family with Martin Cawley and Morag Cunningham at the new restaurant in Dennistoun, in Glasgow s east end The chef behind the popular Six by Nico family of restaurants is to open a new restaurant to support a cause that is close to his heart. Beat 6, which will make its home in Dennistoun, will pair the budget friendly fine dining the brand is known for with social good. All profits from the restaurant will go directly towards the Beatson Cancer Charity, which supports the Beatson West of Scotland Cancer Centre. Restaurateur Nico Simeone s wife Valentina was diagnosed with Non-Hodgkin’s Lymphoma in May of 2015, at the age of 25.